M51
{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone
Created: | 2011-11-08 |
Last modified: | 2020-06-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 60 |
Chiral Atom Count | 2 |
Bond Count | 64 |
Aromatic Bond Count | 11 |
Chemical Component Summary | |
---|---|
Name | {(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone |
Synonyms | Teneligliptin |
Systematic Name (OpenEye OEToolkits) | [(2S,4S)-4-[4-(5-methyl-2-phenyl-pyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone |
Formula | C22 H30 N6 O S |
Molecular Weight | 426.578 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | O=C(N1CCSC1)C5NCC(N4CCN(c3cc(nn3c2ccccc2)C)CC4)C5 |
SMILES | CACTVS | 3.370 | Cc1cc(N2CCN(CC2)[CH]3CN[CH](C3)C(=O)N4CCSC4)n(n1)c5ccccc5 |
SMILES | OpenEye OEToolkits | 1.7.2 | Cc1cc(n(n1)c2ccccc2)N3CCN(CC3)C4CC(NC4)C(=O)N5CCSC5 |
Canonical SMILES | CACTVS | 3.370 | Cc1cc(N2CCN(CC2)[C@@H]3CN[C@@H](C3)C(=O)N4CCSC4)n(n1)c5ccccc5 |
Canonical SMILES | OpenEye OEToolkits | 1.7.2 | Cc1cc(n(n1)c2ccccc2)N3CCN(CC3)[C@H]4C[C@H](NC4)C(=O)N5CCSC5 |
InChI | InChI | 1.03 | InChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1 |
InChIKey | InChI | 1.03 | WGRQANOPCQRCME-PMACEKPBSA-N |
Drug Info: DrugBank
DrugBank ID | DB11950 |
---|---|
Name | Teneligliptin |
Groups | investigational |
Description | Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus. |
Synonyms | Teneligliptin |
Categories |
|
ATC-Code | A10BH08 |
CAS number | 760937-92-6 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL2147777 |
PubChem | 11949652 |
ChEMBL | CHEMBL2147777 |
ChEBI | CHEBI:136042 |